- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Health IT Interoperability Roadmap in the Works
As part of National Health IT Week, the Office of the National Coordinator for Health IT, outlined its 10-year vision to achieve interoperability for health IT.
As part of National Health IT Week, the Office of the National Coordinator for Health IT (ONC), outlined its 10-year vision to achieve interoperability for health IT.
ONC is looking to leverage health IT to increase healthcare quality and lower costs by supporting health broadly, building incrementally over time from the current technology, and maintaining focus on and empowering individuals.
“Our current priority is to focus on interoperability and getting health information to move to follow the patient,” Jodi G. Daniel, JD, MPH, director of the ONC's Office of Policy, explained during a webinar.
She said the expectations laid out were not just ONC’s vision, but what everyone needs to do jointly in order to support interoperability in healthcare. Overall, the 10-year plan is broken out into 3 time periods: 3 years, 6 years, and 10 years.
By 2017, ONC wants to ensure both providers and individuals can send, receive, find, and use a basic set of essential health information. By 2020, the vision calls for expanded sources and users of information to improve healthcare quality and lower costs, as well as increased automation.
Daniel outlined 5 building blocks to realize this 10-year interoperability vision:
• Core technical standards and functions
• Certification to support adoption and optimization of health IT products and services
• Privacy and security protections for health information
• Supportive business, clinical, cultural, and regulatory environments
• Rules of engagement and governance
“ONC will build on our existing governance framework … and principles to ensure individual access, privacy, transparency, responsible financial and business practices, and use of federal standards to support health information exchange,” she said.
Over the next few months, ONC expects to transition from this vision to producing an actionable roadmap. Currently, a governance subgroup of the EHR/HIE Interoperability Workgroup is discussing plans, and they will report in mid-October about what they have come to a consensus on.
ONC is targeting January for a draft of the roadmap, which will then be published and open for comments and feedback.
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
